Zimmer Biomet Holdings (ZBH) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.90
- Estimate
- $1.88
- Surprise
- +1.0%
- Revenue (period 2026-09-30)
- $2.06B
- Score today
- 6.3/10
Revenue source: xbrl.
How the report landed
Zimmer Biomet Holdings (ZBH) beat the $1.88 estimate with adjusted EPS of $1.90 — a modest 1.0% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates ZBH Hold at 6.3/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +1.0% surprise compares with a +4.3% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Concentration risk — Supplier: single-source materials and components
- Analyst target reached - limited upside remaining
- Near 52-week high (2.1% away)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $110.15
- Stop
- $103.63
The stock trades at 27.8× trailing but 12.2× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 76 — a level conventionally read as overbought; gains at these levels often lean on momentum; trading volume is running 2.7× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-05 — shown for context, not personalized investment advice.
ZBH at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $21.01B
- P/E (fwd)
- 12.2
- P/E (ttm)
- 27.8
- 52-week range
- $79.12–$112.55
- Off 52-week high
- 2.1%
- RSI (14)
- 76
- Volume vs avg
- 2.68×
- Score today
- 6.3/10